Junhe Li
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
Papers in
- Co-authors
- Wei Gan (1 shared paper)Jianping Xiong (2 shared papers)Tao Wu (2 shared papers)Can Liu (2 shared papers)Yi Yu (2 shared papers)Jun Chen (2 shared papers)
- Journals
- Clinical & Translational Oncology (1 paper)Cancer Cell (1 paper)JAMA (1 paper)Heliyon (1 paper)Journal of Thoracic Disease (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Junhe Li
4 papers receiving 621 citations
Junhe Li's Hit Papers
Peers
Comparison fields: 5 of 37
- Oncology 224
- Pulmonary and Respiratory Medicine 171
- Surgery 225
- Gastroenterology 26
- Immunology 46
Countries citing papers authored by Junhe Li
This map shows the geographic impact of Junhe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhe Li more than expected).
Fields of papers citing papers by Junhe Li
This network shows the impact of papers produced by Junhe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhe Li. The network helps show where Junhe Li may publish in the future.
Co-authors
The 6 scholars most cited alongside Junhe Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial Hit paper breakdown → | 2022 | 365 |
| 2 | Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer Hit paper breakdown → | 2023 | 256 |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 |
About Junhe Li
Junhe Li is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Insect Science and Renewable Energy, Sustainability and the Environment, having authored 5 papers that have together received 626 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Oncology (224 citations), Pulmonary and Respiratory Medicine (171 citations), Surgery (225 citations), Gastroenterology (26 citations) and Immunology (46 citations). Junhe Li has collaborated with scholars based in China and United States. Frequent co-authors include Wei Gan, Jianping Xiong, Tao Wu, Can Liu, Yi Yu and Jun Chen. Their work appears in journals such as Clinical & Translational Oncology, Cancer Cell, JAMA, Heliyon and Journal of Thoracic Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.